Parametric Portfolio Associates’s Cytosorbents Corp CTSO Stock Holding History

Parametric Portfolio Associates’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$246K	Buy	3,849 +2,925	+317%	+$210K	﹤0.01%	3363
2021 Q4	$77K	Sell	924 -166	-15%	-$18.6K	﹤0.01%	3575
2021 Q3	$177K	Buy	1,090 +364	+50%	+$59.1K	﹤0.01%	3459
2021 Q2	$110K	Sell	726 -65	-8%	-$11K	﹤0.01%	3473
2021 Q1	$137K	Buy	791 +5	+0.6%	+$953	﹤0.01%	3938
2020 Q4	$125K	Buy	786 +23	+3%	+$3.85K	﹤0.01%	3860
2020 Q3	$122K	Sell	763 -8	-1%	-$1.44K	﹤0.01%	3760
2020 Q2	$153K	Buy	771 +11	+1%	+$2.02K	﹤0.01%	3699
2020 Q1	$117K	Buy	760 +247	+48%	+$24.9K	﹤0.01%	3687
2019 Q4	$39K	Buy	+513	New	+$44.8K	﹤0.01%	3932

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Parametric Portfolio Associates's CTSO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Cytosorbents Corp (CTSO) stake by 317% in Q1 2022, buying an estimated $210K and bringing the position to 3,849 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Parametric Portfolio Associates first reported a position in CTSO in Q4 2019 and has held it in 10 quarters since. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

Parametric Portfolio Associates held 3,849 shares of Cytosorbents Corp worth $246K as of Q1 2022.
Parametric Portfolio Associates bought 2,925 Cytosorbents Corp shares in Q1 2022, an estimated $210K.
Cytosorbents Corp made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3363 holding.
Parametric Portfolio Associates first reported a position in Cytosorbents Corp in Q4 2019 and has held it in 10 quarters since.
88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.